COVID-19 Impact on Global Drug Safety Solutions and Pharmacovigilance Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 14-May-2020
No. of pages: 134
Inquire Before Buying

This report focuses on the global Drug Safety Solutions and Pharmacovigilance status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Safety Solutions and Pharmacovigilance development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Pharmaceutical Product Development, LLC

- Drug Safety Solutions Limited

- C3i

- Worldwide Clinical Trials

- Bioclinica

- United Biosource LLC

- Ennov

- AB Cube

- Covance Inc.

- Accenture

- PRA Health Sciences, Inc.

- Ergomed

- IQVIA

- Genpact

- Cognizant

- Parexel International Corporation

- ArisGlobal

- ICON plc

- Oracle

- Syneos Health

Market segment by Type, the product can be split into

- Standard Form

- Customized Form

Market segment by Application, split into

- Biotechnology and Pharmaceuticals

- Contract Research Organization (CROS)

- Hospital

- KPO / BPO

- Healthcare Institutions

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Drug Safety Solutions and Pharmacovigilance status, future forecast, growth opportunity, key market and key players.

- To present the Drug Safety Solutions and Pharmacovigilance development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Drug Safety Solutions and Pharmacovigilance are as follows:

- History Year: 2015-2019

- Base Year: 2019

- Estimated Year: 2020

- Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

COVID-19 Impact on Global Drug Safety Solutions and Pharmacovigilance Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Safety Solutions and Pharmacovigilance Revenue
1.4 Market Analysis by Type
1.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Standard Form
1.4.3 Customized Form
1.5 Market by Application
1.5.1 Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology and Pharmaceuticals
1.5.3 Contract Research Organization (CROS)
1.5.4 Hospital
1.5.5 KPO / BPO
1.5.6 Healthcare Institutions
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Drug Safety Solutions and Pharmacovigilance Industry Impact
1.6.1 How the Covid-19 is Affecting the Drug Safety Solutions and Pharmacovigilance Industry
1.6.1.1 Drug Safety Solutions and Pharmacovigilance Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Drug Safety Solutions and Pharmacovigilance Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Drug Safety Solutions and Pharmacovigilance Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Drug Safety Solutions and Pharmacovigilance Market Perspective (2015-2026)
2.2 Drug Safety Solutions and Pharmacovigilance Growth Trends by Regions
2.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Share by Regions (2015-2020)
2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Drug Safety Solutions and Pharmacovigilance Market Growth Strategy
2.3.6 Primary Interviews with Key Drug Safety Solutions and Pharmacovigilance Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Market Size
3.1.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue (2015-2020)
3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
3.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2019
3.3 Drug Safety Solutions and Pharmacovigilance Key Players Head office and Area Served
3.4 Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
3.5 Date of Enter into Drug Safety Solutions and Pharmacovigilance Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2015-2020)
4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2021-2026)
5 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Application (2015-2026)
5.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
6.2 Drug Safety Solutions and Pharmacovigilance Key Players in North America (2019-2020)
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
7 Europe
7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
7.2 Drug Safety Solutions and Pharmacovigilance Key Players in Europe (2019-2020)
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
8 China
8.1 China Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
8.2 Drug Safety Solutions and Pharmacovigilance Key Players in China (2019-2020)
8.3 China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
8.4 China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
9 Japan
9.1 Japan Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
9.2 Drug Safety Solutions and Pharmacovigilance Key Players in Japan (2019-2020)
9.3 Japan Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
9.4 Japan Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
10.2 Drug Safety Solutions and Pharmacovigilance Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
11 India
11.1 India Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
11.2 Drug Safety Solutions and Pharmacovigilance Key Players in India (2019-2020)
11.3 India Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
11.4 India Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Drug Safety Solutions and Pharmacovigilance Market Size (2015-2020)
12.2 Drug Safety Solutions and Pharmacovigilance Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020)
12.4 Central & South America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pharmaceutical Product Development, LLC
13.1.1 Pharmaceutical Product Development, LLC Company Details
13.1.2 Pharmaceutical Product Development, LLC Business Overview and Its Total Revenue
13.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
13.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020))
13.1.5 Pharmaceutical Product Development, LLC Recent Development
13.2 Drug Safety Solutions Limited
13.2.1 Drug Safety Solutions Limited Company Details
13.2.2 Drug Safety Solutions Limited Business Overview and Its Total Revenue
13.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
13.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.2.5 Drug Safety Solutions Limited Recent Development
13.3 C3i
13.3.1 C3i Company Details
13.3.2 C3i Business Overview and Its Total Revenue
13.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
13.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.3.5 C3i Recent Development
13.4 Worldwide Clinical Trials
13.4.1 Worldwide Clinical Trials Company Details
13.4.2 Worldwide Clinical Trials Business Overview and Its Total Revenue
13.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
13.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.4.5 Worldwide Clinical Trials Recent Development
13.5 Bioclinica
13.5.1 Bioclinica Company Details
13.5.2 Bioclinica Business Overview and Its Total Revenue
13.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
13.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.5.5 Bioclinica Recent Development
13.6 United Biosource LLC
13.6.1 United Biosource LLC Company Details
13.6.2 United Biosource LLC Business Overview and Its Total Revenue
13.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
13.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.6.5 United Biosource LLC Recent Development
13.7 Ennov
13.7.1 Ennov Company Details
13.7.2 Ennov Business Overview and Its Total Revenue
13.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
13.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.7.5 Ennov Recent Development
13.8 AB Cube
13.8.1 AB Cube Company Details
13.8.2 AB Cube Business Overview and Its Total Revenue
13.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
13.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.8.5 AB Cube Recent Development
13.9 Covance Inc.
13.9.1 Covance Inc. Company Details
13.9.2 Covance Inc. Business Overview and Its Total Revenue
13.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
13.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.9.5 Covance Inc. Recent Development
13.10 Accenture
13.10.1 Accenture Company Details
13.10.2 Accenture Business Overview and Its Total Revenue
13.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
13.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
13.10.5 Accenture Recent Development
13.11 PRA Health Sciences, Inc.
10.11.1 PRA Health Sciences, Inc. Company Details
10.11.2 PRA Health Sciences, Inc. Business Overview and Its Total Revenue
10.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
10.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.11.5 PRA Health Sciences, Inc. Recent Development
13.12 Ergomed
10.12.1 Ergomed Company Details
10.12.2 Ergomed Business Overview and Its Total Revenue
10.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
10.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.12.5 Ergomed Recent Development
13.13 IQVIA
10.13.1 IQVIA Company Details
10.13.2 IQVIA Business Overview and Its Total Revenue
10.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
10.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.13.5 IQVIA Recent Development
13.14 Genpact
10.14.1 Genpact Company Details
10.14.2 Genpact Business Overview and Its Total Revenue
10.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
10.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.14.5 Genpact Recent Development
13.15 Cognizant
10.15.1 Cognizant Company Details
10.15.2 Cognizant Business Overview and Its Total Revenue
10.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
10.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.15.5 Cognizant Recent Development
13.16 Parexel International Corporation
10.16.1 Parexel International Corporation Company Details
10.16.2 Parexel International Corporation Business Overview and Its Total Revenue
10.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
10.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.16.5 Parexel International Corporation Recent Development
13.17 ArisGlobal
10.17.1 ArisGlobal Company Details
10.17.2 ArisGlobal Business Overview and Its Total Revenue
10.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
10.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.17.5 ArisGlobal Recent Development
13.18 ICON plc
10.18.1 ICON plc Company Details
10.18.2 ICON plc Business Overview and Its Total Revenue
10.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
10.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.18.5 ICON plc Recent Development
13.19 Oracle
10.19.1 Oracle Company Details
10.19.2 Oracle Business Overview and Its Total Revenue
10.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
10.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.19.5 Oracle Recent Development
13.20 Syneos Health
10.20.1 Syneos Health Company Details
10.20.2 Syneos Health Business Overview and Its Total Revenue
10.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
10.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
10.20.5 Syneos Health Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Drug Safety Solutions and Pharmacovigilance Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Safety Solutions and Pharmacovigilance Revenue
Table 3. Ranking of Global Top Drug Safety Solutions and Pharmacovigilance Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Standard Form
Table 6. Key Players of Customized Form
Table 7. COVID-19 Impact Global Market: (Four Drug Safety Solutions and Pharmacovigilance Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Drug Safety Solutions and Pharmacovigilance Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Drug Safety Solutions and Pharmacovigilance Players to Combat Covid-19 Impact
Table 12. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Drug Safety Solutions and Pharmacovigilance Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Drug Safety Solutions and Pharmacovigilance Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2015-2020)
Table 16. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Drug Safety Solutions and Pharmacovigilance Market Growth Strategy
Table 22. Main Points Interviewed from Key Drug Safety Solutions and Pharmacovigilance Players
Table 23. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2015-2020) (Million US$)
Table 24. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players (2015-2020)
Table 25. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2019)
Table 26. Global Drug Safety Solutions and Pharmacovigilance by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
Table 29. Date of Enter into Drug Safety Solutions and Pharmacovigilance Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 32. Global Drug Safety Solutions and Pharmacovigilance Market Size Share by Type (2015-2020)
Table 33. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2021-2026)
Table 34. Global Drug Safety Solutions and Pharmacovigilance Market Size Share by Application (2015-2020)
Table 35. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 36. Global Drug Safety Solutions and Pharmacovigilance Market Size Share by Application (2021-2026)
Table 37. North America Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 39. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 40. North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 41. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 42. North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 43. Europe Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 45. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 47. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 49. China Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 50. China Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 51. China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 52. China Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 53. China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 54. China Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 55. Japan Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 57. Japan Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 59. Japan Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 63. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 65. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 67. India Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 68. India Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 69. India Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 70. India Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 71. India Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 72. India Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Drug Safety Solutions and Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Drug Safety Solutions and Pharmacovigilance Market Share (2019-2020)
Table 75. Central & South America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2015-2020)
Table 77. Central & South America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2015-2020)
Table 79. Pharmaceutical Product Development, LLC Company Details
Table 80. Pharmaceutical Product Development, LLC Business Overview
Table 81. Pharmaceutical Product Development, LLC Product
Table 82. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 83. Pharmaceutical Product Development, LLC Recent Development
Table 84. Drug Safety Solutions Limited Company Details
Table 85. Drug Safety Solutions Limited Business Overview
Table 86. Drug Safety Solutions Limited Product
Table 87. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 88. Drug Safety Solutions Limited Recent Development
Table 89. C3i Company Details
Table 90. C3i Business Overview
Table 91. C3i Product
Table 92. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 93. C3i Recent Development
Table 94. Worldwide Clinical Trials Company Details
Table 95. Worldwide Clinical Trials Business Overview
Table 96. Worldwide Clinical Trials Product
Table 97. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 98. Worldwide Clinical Trials Recent Development
Table 99. Bioclinica Company Details
Table 100. Bioclinica Business Overview
Table 101. Bioclinica Product
Table 102. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 103. Bioclinica Recent Development
Table 104. United Biosource LLC Company Details
Table 105. United Biosource LLC Business Overview
Table 106. United Biosource LLC Product
Table 107. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 108. United Biosource LLC Recent Development
Table 109. Ennov Company Details
Table 110. Ennov Business Overview
Table 111. Ennov Product
Table 112. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 113. Ennov Recent Development
Table 114. AB Cube Business Overview
Table 115. AB Cube Product
Table 116. AB Cube Company Details
Table 117. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 118. AB Cube Recent Development
Table 119. Covance Inc. Company Details
Table 120. Covance Inc. Business Overview
Table 121. Covance Inc. Product
Table 122. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 123. Covance Inc. Recent Development
Table 124. Accenture Company Details
Table 125. Accenture Business Overview
Table 126. Accenture Product
Table 127. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 128. Accenture Recent Development
Table 129. PRA Health Sciences, Inc. Company Details
Table 130. PRA Health Sciences, Inc. Business Overview
Table 131. PRA Health Sciences, Inc. Product
Table 132. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 133. PRA Health Sciences, Inc. Recent Development
Table 134. Ergomed Company Details
Table 135. Ergomed Business Overview
Table 136. Ergomed Product
Table 137. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 138. Ergomed Recent Development
Table 139. IQVIA Company Details
Table 140. IQVIA Business Overview
Table 141. IQVIA Product
Table 142. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 143. IQVIA Recent Development
Table 144. Genpact Company Details
Table 145. Genpact Business Overview
Table 146. Genpact Product
Table 147. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 148. Genpact Recent Development
Table 149. Cognizant Company Details
Table 150. Cognizant Business Overview
Table 151. Cognizant Product
Table 152. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 153. Cognizant Recent Development
Table 154. Parexel International Corporation Company Details
Table 155. Parexel International Corporation Business Overview
Table 156. Parexel International Corporation Product
Table 157. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 158. Parexel International Corporation Recent Development
Table 159. ArisGlobal Company Details
Table 160. ArisGlobal Business Overview
Table 161. ArisGlobal Product
Table 162. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 163. ArisGlobal Recent Development
Table 164. ICON plc Company Details
Table 165. ICON plc Business Overview
Table 166. ICON plc Product
Table 167. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 168. ICON plc Recent Development
Table 169. Oracle Company Details
Table 170. Oracle Business Overview
Table 171. Oracle Product
Table 172. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 173. Oracle Recent Development
Table 174. Syneos Health Company Details
Table 175. Syneos Health Business Overview
Table 176. Syneos Health Product
Table 177. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2015-2020) (Million US$)
Table 178. Syneos Health Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2020 VS 2026
Figure 2. Standard Form Features
Figure 3. Customized Form Features
Figure 4. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2020 VS 2026
Figure 5. Biotechnology and Pharmaceuticals Case Studies
Figure 6. Contract Research Organization (CROS) Case Studies
Figure 7. Hospital Case Studies
Figure 8. KPO / BPO Case Studies
Figure 9. Healthcare Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Safety Solutions and Pharmacovigilance Report Years Considered
Figure 12. Global Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions: 2020 VS 2026
Figure 14. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2019
Figure 17. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2019
Figure 19. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Pharmaceutical Product Development, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 28. Drug Safety Solutions Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 30. C3i Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 32. Worldwide Clinical Trials Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 34. Bioclinica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 36. United Biosource LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 38. Ennov Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 40. AB Cube Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 42. Covance Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 44. Accenture Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 46. PRA Health Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 48. Ergomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 50. IQVIA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 52. Genpact Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 54. Cognizant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 56. Parexel International Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2015-2020)
Figure 58. ArisGlobal Total
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs